SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (18617)2/9/1999 6:56:00 PM
From: VLAD  Read Replies (2) of 23519
 
To all!!

Watch Entremed tomorrow.

biz.yahoo.com

Pretty sick how naive the investment community really is. Media hype pops the share price from 12 to over $80.00 in early May 1998 and has been in a trading range between $20 to $35.00 for the past 3+ months. This stock moved on total bs hype regarding 2 proteins that supposedly cut off blood flow to tumors in mice. Some here (myself included) have made some remarks regarding how Vivus has yet to release a single press release about Dr G. Christ's factual and scientific research which has proven that genetic therapy in ED has a very promising future. Injecting Calcium channel pumps (which were produced from human genes) into impotent mouse penile tissue was proven to reverse organic vascular impotence. This is proven fact not hype yet Vivus (I am told because of the past share holder lawsuit) has done not an ounce of media exposure towards this scientific break through. IMO Christ needs to repeat his experiment in primates if the FDA will not approve phase I clinical trials in the very near future. His research will again be proven valid if he can repeat it on monkeys. DaiS, do you know anything about this?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext